GEM05 for Patients With Multiple Myeloma Under 65 Years
NCT00461747
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
390
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
VBMCP/VBAD/Velcade
DRUG:
Thalidomide/Dexamethasone
DRUG:
Velcade/Thalidomide/Dexamethasone
Sponsor
PETHEMA Foundation